ribavirin has been researched along with Encephalopathy, Toxic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hopwood, M | 1 |
Deutsch, M; Hadziyannis, S; Koskinas, J; Mailis, A; Tolis, G; Tzannos, K; Vassilopoulos, D | 1 |
2 other study(ies) available for ribavirin and Encephalopathy, Toxic
Article | Year |
---|---|
Perspectives of a self-selected sample of former patients on the long-term health outcomes of interferon-based hepatitis C treatments: an exploratory study.
Topics: Adult; Aftercare; Anorexia; Antiviral Agents; Attitude of Health Personnel; Chronic Disease; Cognition Disorders; Depression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neurotoxicity Syndromes; New South Wales; Patient Education as Topic; Qualitative Research; Quality of Life; Recurrence; Ribavirin; Sarcoidosis; Self Report; Severity of Illness Index; Treatment Outcome; Victoria | 2013 |
Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neurotoxicity Syndromes; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |